Advances in infant heart transplantation
This article has no abstract so we have provided the first paragraph of the full text.
Transplantation of ABO-incompatible allografts is not generally feasible, except in some cases of kidney and liver transplantation in heavily immunosuppressed individuals. A new study by Fan et al., published in Nature Medicine, has demonstrated the development of B-cell tolerance to donor blood group A and B antigens in infants undergoing ABO-incompatible heart transplantation. This finding is the first illustration of intentional tolerance induction in human infants.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
